Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › FGFR2 inhibitors for the treatment of cholangiocarcinoma

FGFR2 inhibitors for the treatment of cholangiocarcinoma

US Patent 11707463 · Granted Jul 25, 2023

Estimated economic value: $177,238,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FGFR2 inhibitors for the treatment of cholangiocarcinoma2025
Methods of treating myelodysplastic syndrome2025
Methods of treating myelodysplastic syndrome2024
Treatment of cholangiocarcinoma2024
Combination therapy comprising glucose reabsorption inhibitors and PPAR modulato2012
Combination therapy comprising glucose reabsorption inhibitors and retinoid-X re2012
Substituted amino acids as erythropoietin mimetics2008
Substituted amino acids as erythropoietin mimetics2006
Combination therapy comprising glucose reabsorption inhibitors and retinoid-X re2005
Substituted amino acids as erythropoietin mimetics2004
Substituted amino acids as erythropoietin mimetics2001